|
"wu sy"的相關文件
顯示項目 146-170 / 192 (共8頁)
<< < 1 2 3 4 5 6 7 8 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2009-08-13 |
Synthesis and evaluation of 3-aroylindoles as anticancer agents: Metabolite approach
|
Wu, YS;Coumar, MS;Chang, JY;Sun, HY;Kuo, FM;Kuo, CC;Chen, YJ;Chang, CY;Hsiao, CL;Liou, JP;Chen, CP;Yao, HT;Chiang, YK;Tan, UK;Chen, CT;Chu, CY;Wu, SY;Yeh, TK;Lin, CY;Hsieh, HP |
| 中國醫藥大學 |
2009-08 |
Synthesis and Evaluation of 3-Aroylindoles as Anticancer Agents: Metabolite Approach.
|
(Wu YS); (Coumar MS); (Chang JY); (Sun HY); (Kuo FM); (Kuo CC); (Chen YJ); (Chang CY); (Hsiao CL); (Liou JP); (Chen CP); 姚賢宗(Hsien-Tsung Yao); (Chiang YK); (Tan UK); (Chen CT); (Chu CY); (Wu SY); (Yeh TK); (Lin CY); (Hsieh HP)* |
| 國家衛生研究院 |
2009-07-23 |
Generation of ligand-based pharmacophore model and virtual screening for identification of novel tubulin inhibitors with potent anticancer activity
|
Chiang, YK;Kuo, CC;Wu, YS;Chen, CT;Coumar, MS;Wu, JS;Hsieh, HP;Chang, CY;Jseng, HY;Wu, MH;Leou, JS;Song, JS;Chang, JY;Lyu, PC;Chao, YS;Wu, SY |
| 國家衛生研究院 |
2009-06 |
A three-dimensional pharmacophore model for dipeptidyl peptidase IV inhibitiors [Erratum: European Journal of Medicinal Chemistry. 2008 Aug;43(8):1603-1611.]
|
Lu, IL;Tsai, KC;Chiang, YK;Jiaang, WT;Wu, SH;Mahindroo, N;Chien, CH;Lee, SJ;Chen, X;Chao, YS;Wu, SY |
| 國家衛生研究院 |
2009-05-15 |
Endoplasmic reticulum stress triggers XBP-1-mediated up-regulation of an EBV oncoprotein in nasopharyngeal carcinoma
|
Hsiao, JR;Chang, KC;Chen, CW;Wu, SY;Su, IJ;Hsu, MC;Jin, YT;Tsai, ST;Takada, K;Chang, Y |
| 國家衛生研究院 |
2009-04-23 |
Design and structural analysis of novel pharmacophores for potent and selective peroxisome proliferator-activated receptor gamma agonists
|
Lin, CH;Peng, YH;Coumar, MS;Chittimalla, SK;Liao, CC;Lyn, PC;Huang, CC;Lien, TW;Lin, WH;Hsu, JT;Cheng, JH;Chen, X;Wu, JS;Chao, YS;Lee, HJ;Juo, CG;Wu, SY;Hsieh, HP |
| 國家衛生研究院 |
2009-03 |
Discovery and development of novel furano-pyrimidine analogs as Aurora kinase inhibitors
|
Hsieh, HP;Coumar, MS;Lin, CW;Reddy, GR;Tsai, MT;Lin, WH;Hsu, TA;Wu, SY |
| 國家衛生研究院 |
2009-02-26 |
Structure-based drug design of novel aurora kinase a inhibitors: Structural basis for potency and specificity
|
Coumar, MS;Leou, JS;Shukla, P;Wu, JS;Dixit, AK;Lin, WH;Chang, CY;Lien, TW;Tan, UK;Chen, CH;Hsu, JTA;Chao, YS;Wu, SY;Hsieh, HP |
| 國家衛生研究院 |
2009-01-22 |
Pyrrolidine compounds
|
Chao, YS;Chen, X;Hsieh, HP;Jiaang, WT;Wu, SY |
| 國立臺灣大學 |
2009-01 |
Effect of benazepril on systemic blood pressure in small breed dogs with chronic degenerative valvular diseases.
|
Wu, SY; Huang, HP |
| 國家衛生研究院 |
2008-12-25 |
Synthesis and structure-activity relationships of 2-amino-1-aroylnaphthalene and 2-hydroxy-1-aroylnaphthalenes as potent antitubulin agents
|
Reddy, GR;Kuo, CC;Tan, UK;Coumar, MS;Chang, CY;Chiang, YK;Lai, MJ;Yeh, JY;Wu, SY;Chang, JY;Liou, JP;Hsieh, HP |
| 國立臺灣大學 |
2008-11 |
YC-1 induces apoptosis of human renal carcinoma A498 cells in vitro and in vivo through activation of the JNK pathway.
|
Wu, SY; Pan, SL; Chen, TH; Liao, CH; Huang, DY; Guh, JH; Chang, YL; Kuo, SC; Lee, FY; Teng, CM. |
| 國家衛生研究院 |
2008-08 |
A three-dimensional pharmacophore model for dipeptidyl peptidase IV inhibitors
|
Lu, IL;Tsai, KC;Chiang, YK;Jiaang, WT;Wu, SH;Mahindroo, N;Chien, CH;Lee, SJ;Chen, X;Chao, YS;Wu, SY |
| 國家衛生研究院 |
2008-07-21 |
吡咯啉啶化合物
|
Jiaang, WT;Wu, SY;Chen, X;Chao, YS;Hsieh, HP |
| 國家衛生研究院 |
2008-07-01 |
Pyrrolidine compounds
|
Jiaang, WT;Chen, X;Wu, SY;Hsieh, HP;Chao, YS |
| 國家衛生研究院 |
2008-04 |
Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells
|
Hsu, M; Wu, SY; Chang, SS; Su, IJ; Tsai, CH; Lai, SJ; Shiau, AL; Takada, K; Chang, Y |
| 國家衛生研究院 |
2008-03-01 |
Aurora kinase A inhibitors: Identification, SAR exploration and molecular modeling of 6,7-dihydro-4H-pyrazolo-[1,5-a]pyrrolo[3,4-d]pyrimidine-5,8-dione scaffold
|
Coumar, MS; Wu, JS; Leou, JS; Tan, UK; Chang, CY; Chang, TY; Lin, WH; Hsu, JTA; Chao, YS; Wu, SY; Hsieh, HP |
| 國家衛生研究院 |
2008 |
Structure-based inhibitors exhibit differential activities against Helicobacter pylori and Escherichia coli undecaprenyl pyrophosphate synthases
|
Kuo, CJ; Guo, RT; Lu, IL; Liu, HG; Wu, SY; Ko, TP; Wang, AHJ; Liang, PH |
| 臺北醫學大學 |
2008 |
Synthesis and Structure-Activity Relationships of 2-Amino and 2-Hydroxy-1-Aroylnaphthalenes as Potent Antitubulin Agents
|
劉景平; Reddy GR; Kuo CC; Tan UK; Coumar MS; Chang CY; Lai MJ; Wu SY; Chang JY; Liou JP; Hsieh HP |
| 臺北醫學大學 |
2008 |
Domain and Functional Analysis of a Novel Platelet-Endothelial Cell Surface Protein; SCUBE1.
|
鄭建睿; Tu CF; Yan YT; Wu SY; Djoko B; Tsai MT; Cheng CJ; Yang RB |
| 國立臺灣大學 |
2008 |
Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells.
|
Hsu, M; Wu, SY; Chang, SS; Su, IJ; Tsai, CH; Lai, SJ; Shiau, AL; Takada, K; Chang, Y |
| 國家衛生研究院 |
2007 |
Crystal structures and computer screened inhibitors of Helicobacter pylori undecaprenyl pyrophosphate synthase
|
Kuo, CJ;Guo, RT;Lu, IL;Liu, HG;Wu, SY;Ko, TP;Wang, AHJ;Liang, PH |
| 臺北醫學大學 |
2007 |
Menthol inhibits WEHI-3 leukemia cells in vitro and in vivo
|
楊沂淵; Lu HF; Liu JY; Hsueh SC; Yang YY; Yang JS; Tan TW; Kok LF; Lu CC; Lan SH; Wu SY; et al.; |
| 國家衛生研究院 |
2006-10-19 |
Structural basis for the structure-activity relationships of peroxisome proliferator-activated receptor agonists
|
Mahindroo, N; Peng, YH; Lin, CH; Tan, UK; Prakash, E; Lien, TW; Lu, IL; Lee, HJ; Hsu, JTA; Chen, X; Liao, CC; Lyu, PC; Chao, YS; Wu, SY; Hsieh, HP |
| 國家衛生研究院 |
2006-08-24 |
Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease
|
Lu, IL; Mahindroo, N; Liang, PH; Peng, YH; Kuo, CJ; Tsai, KC; Hsieh, HP; Chao, YS; Wu, SY |
顯示項目 146-170 / 192 (共8頁)
<< < 1 2 3 4 5 6 7 8 > >>
每頁顯示[10|25|50]項目
|
